Show all abstracts Show selected abstracts Add to my list |
|
|
Article: Apertura y homenaje 2013 |
|
Pan Am J Ophthalmol 2013, 12:91 (1 July 2013) |
HTML Full Text not available [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Article: Dr. Sebastião cronemberger and co-workers are the recipients of vision Pan-America Editor's choice Award 2013 |
|
Paulo E C. Dantas Pan Am J Ophthalmol 2013, 12:90 (1 July 2013) |
HTML Full Text not available [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Article: Ranibizumab for choroidal neovascularization following atrophic involution of adult-onset foveomacular vitelliform dystrophy |
|
Sebastián Martínez-Castillo, Rosa Dolz-Marco, Enrique España-Gregori, Roberto Gallego-Pinazo, Lihteh Wu, J Fernando Arévalo, Manuel Díaz-Llopis Pan Am J Ophthalmol 2013, 12:81 (1 July 2013)
We report a case of adult-onset foveomacular vitelliform dystrophy complicated with atrophic involution and subsequent choroidal neovascularization and treated with intravitreal ranibizumab.
A 71-year-old woman diagnosed with adult-onset foveomacular vitelliform dystrophy experienced a progression of the vitelliform lesion to the atrophic stage in her left eye immediately after cataract surgery. Best-corrected visual acuity decreased from 0.5 to 0.16. Ten months later, the patient was referred with new worsening of her visual acuity (0.05) and metamorphopsia. The spectral-domain optical coherence tomography confirmed the presence of type 2 choroidal neovascularization next to the atrophic area. The patient was treated with 2 monthly injections of ranibizumab.
Spectral-domain optical coherence tomography images improved significantly and her best-corrected visual acuity increased to 0.20 associated with subjective improvement of metamorphopsia.
Ranibizumab may be effective for choroidal neovascularization in patients with adult-onset foveomacular vitelliform dystrophy.
|
[ABSTRACT] HTML Full Text not available [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Article: Tratamiento combinado de hemorragias subretinianas con activador del plasminógeno tisular recombinante (rtPA), gas y Ranibizumab intravítreos; Combined intravitreous therapy for subretinal hemorrhage with recombinant tissue plasminogen activator), gas and Ranibizumab |
|
Miriam García-Fernández, Ana García Alonso, Marta Fonollá Gil Pan Am J Ophthalmol 2013, 12:75 (1 July 2013)
Purpose: To present six cases of macular suberetinal hemorrhage who underwent intravitreal treatment with rtPA, ranibizumab and SF6.
Methods: Size and location of the hemorrhage and visual acuity were evaluated prior and after treatment.
Results: Mean pretreatment visual acuity was hand movements at one meter, and three months later, 0.18 (decimal notation) (p>0.05). A partial displacement of de suberetinal hemorrhage from the fovea was achieved in all patients.
Discussion: This triple procedure is an useful option for the treatment of suberetinal hemorrhage. However, the tissular damage associated to the subjacent disease in some cases does not allow significant functional improvement.
|
[ABSTRACT] HTML Full Text not available [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Article: Optical coherence tomography findings in macular hole complicating exudative age-related macular degeneration treated with ranibizumab |
|
Rosa Dolz-Marco, Roberto Gallego-Pinazo, J Fernando Arévalo, Lihteh Wu, M Dolores Pinazo-Durán, Manuel Díaz-Llopis Pan Am J Ophthalmol 2013, 12:73 (1 July 2013)
Purpose: To analyze the prevalence and morphometric characteristics of macular hole development in patients with neovascular age-related macular degeneration treated with ranibizumab.
Methods: Patients diagnosed of neovascular age-related macular degeneration from January 2009 to December 2010 have been analyzed. Measurement of visual acuity and optical coherence tomography were scheduled.
Results: Two hundred and thirteen eyes (patients) with exudative age-related macular degeneration were analyzed. Development of macular hole was evidenced in 4 eyes (1,9%)
Discussion: Macular hole formation is a severe complication in patients with choroidal neovascularization treated with ranibizumab, frequently undervalued, which interferes with final outcome.
|
[ABSTRACT] HTML Full Text not available [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Article: Bayesian methods and decision making in glaucoma  |
|
Niro Kasahara Pan Am J Ophthalmol 2013, 12:69 (1 July 2013)
This article reviews the Bayesian statistical approach to diagnostic test analysis and application in the management of glaucoma patients. The central idea of the Bayesian method is the use of study data to update the state of knowledge about a quantity of interest. In diagnostic test analysis, the Bayesian approach explicitly elicits a clear interpretation of chances of a particular eye disease given a positive test result. The Bayesian method also provides a reasonable rationale for deciding whether to perform a laser iridotomy in a patient with occludable angles. We present several literature examples of Bayesian methods in practice, especially as it relates to glaucoma evaluation and progression.
|
[ABSTRACT] HTML Full Text not available [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|